Tags:DrugFastGrowthLifeProductTechnology
Aura Biosciences (Cambridge, Massachusetts) develops tumor targeted viral-like nanoparticles which can encapsulate a wide range of payloads. Aura’s lead product is in clinical trials against ocular melanoma. — Aurabiosciences.com
Total raised: $103M

Investors 4

Funding Rounds 5

DateSeriesAmountInvestorsDeal News
02.04.2019Series D$40M--
21.12.2017Series C$30MArix Biosc...-
29.09.2016-$8M--
05.03.2015Series B$21M--
15.08.2014-$4M--

Mentions in press and media 14

DateTitleDescriptionCategoryAuthorSource
23.03.2021Aura Biosc...Aura Biosciences has raised $8...--pitchbook....
22.03.2021Aura Biosc...CAMBRIDGE, Mass.--(BUSINESS WI...--oaoa.com/n...
03.04.2019Aura Biosc...Aura Biosciences, a developer ...--pitchbook....
02.04.2019Aura Biosc...Aura Biosciences, a Cambridge,...USA-finsmes.co...
02.04.2019Daily fund...DynamiCare raised $4.1M; OnSca...-Kristin Ka...vator.tv/n...
21.12.2017Aura Biosc...CAMBRIDGE, Mass.--(BUSINESS WI...--citybizlis...
21.12.2017Aura Biosc...Aura Biosciences, a Cambridge,...USA-finsmes.co...
21.12.2017Arix Biosc...---arixbiosci...
29.09.2016Aura Biosc...Aura Biosciences, a Cambridge,...USA-finsmes.co...
29.09.2016Aura Biosc...CAMBRIDGE, Mass.--(BUSINESS WI...--citybizlis...
Show more